Article
Anecortave acetate found to safe, effective for inhibiting CNV growthin AMD patients
Anecortave acetate (Retaane), a potent angiostatic agent, has been shownto be safe and superior to placebo in reducing loss of vision from baseline,avoiding severe vision loss, and inhibiting the growth of CNV membranesin patients with age-related macular degeneration (AMD), reported JasonS. Slakter, MD, who spoke during the American Academy of Ophthalmology annualmeeting.
Related Videos
Related Content
Published: December 26th 2024 | Updated: December 26th 2024
Exploring electrical stimulation therapy: A promising approach to vision loss in optic neuropathies
Published: December 26th 2024 | Updated: December 26th 2024
Study: Diabetes does not significantly impact outcomes of epiretinal membrane surgery
